Influenza vaccination uptake amongst pregnant women and maternal care providers is suboptimal

doi:10.1016/j.vaccine.2012.04.012

Vaccine

Volume 30, Issue 27, 8 June 2012, Pages 4055-4059

https://doi.org/10.1016/j.vaccine.2012.04.012 Get rights and content

Abstract

Objective

To assess the uptake of influenza vaccination by pregnant women and maternity care providers and explore their attitudes towards influenza vaccination.

Design, setting and participants

Cross-sectional survey administered in a Victorian tertiary level public hospital to 337 pregnant women and 96 maternity care providers.

Results

31.3% of patients planned to or had received influenza vaccination this year, but only a quarter had received education about influenza. Women were more likely to receive influenza vaccination if they had been vaccinated in the last two years (RR 4.5, 95% CI: 3.1–6.4, p < 0.001), received education about influenza (RR 2.3, 95% CI: 1.6–3.2, p < 0.001) or believed that they were at high risk of influenza-related complications while pregnant (RR 2.0, 95% CI: 1.4–2.7, p < 0.001). While only 56.8% of maternity care providers believed pregnant women were at high risk of influenza-related complications, 72.9% would recommend influenza vaccination to all pregnant women. Of the maternity care providers studied, 69% planned to or had been vaccinated in 2011, with this group more likely to recommend vaccination to their patients (RR 2.0, 95% CI: 1.3–3.0, p < 0.001). Significantly more maternity care providers indicated that they would routinely recommend influenza vaccination than the proportion of patients who reported receiving education.

Conclusions

Influenza vaccination rates in pregnant women are low, reflecting inadequate patient education despite most maternity care providers indicating that they would routinely recommend influenza vaccination. Increasing influenza vaccination uptake by women in pregnancy will require better education of both women and maternity care providers.

Highlights

► We assessed the uptake of influenza vaccination in pregnant women and maternity care providers. ► We assessed factors that influence vaccination in these groups. ► We found influenza vaccination rates to be low in these populations. ► Pregnant women were more likely to receive vaccine if their maternity care provider was vaccinated. ► Increased education of both pregnant women and maternity care providers is required.

Introduction

Pregnant women are at increased risk of severe illness from influenza compared with healthy non-pregnant individuals [1], [2]. This was particularly evident during the H1N1/09 pandemic, in which a Victorian study of 43 hospitalised pregnant women showed large proportions of women admitted for both respiratory complications, including pneumonia and respiratory failure, and pregnancy complications, such as a four-fold rise in pre-term labour [1]. A similar United States study of 34 women in the same H1N1/09 pandemic concluded that pregnant women had a greater than four-fold increase in hospitalisations compared to the general population [2]. In both case series, the risk of morbidity and mortality from influenza infection appeared to increase with length of gestation.

Limited data exists on the safety and efficacy of influenza vaccination in pregnancy, with few studies of reasonably small, selected populations published. However, available literature suggests that influenza vaccination is safe and effective for pregnant women [3], [4], [5], with a 36% reduction in respiratory illnesses [6]. Likewise, the vaccination appears safe for the foetus, with no increased risks of congenital abnormality or miscarriage [3], [4], [5]. Evidence is also emerging that maternal influenza vaccination confers protection for infants in the first 6 months of life, with a 41% risk reduction in laboratory-confirmed influenza virus [7] and a 45-48% reduction in influenza hospitalisations [8].

National policies on influenza vaccination in pregnancy vary widely around the world, reflecting the uncertainty surrounding its safety and efficacy. In Australia, the National Health and Medical Research Council recommends that all pregnant women who will be in their second or third trimester during the influenza season, including those in their first trimester of pregnancy at time of vaccination, should receive the inactivated trivalent influenza vaccine [9]. This vaccine is available free-of-charge to all pregnant women under the Australian National Immunisation Programme.

Despite data demonstrating an increased risk of influenza-related complications, and national recommendations for influenza vaccination, coverage levels in pregnant women are still amongst the lowest for any group considered at high risk for influenza-related complications [10]. United States seasonal influenza vaccination rates in pregnant women have ranged between 10% and 15% [11], while a recent West Australian study demonstrated a H1N1/09 influenza vaccination rate of only 6.7% [12]. However, Australian-specific data remains scarce.

The objectives of this report were to assess uptake of influenza vaccination among pregnant women and maternity care providers, and to explore their attitudes towards influenza vaccination.

Section snippets

Methods

A cross-sectional survey was conducted at Monash Medical Centre (Clayton, Victoria), a public metropolitan tertiary hospital with about 3500 births per annum. The study took place over a three-week period (27 April 2011 to 18 May 2011). The study was approved by the Southern Health Human Research Ethics Committee.

Pregnant women (patients) attending the general antenatal clinics were approached by one of the investigators (AL or AAH) and asked to complete an anonymous, self-administered

Pregnant women

Three hundred and thirty seven patient questionnaires were completed (95% in English, 4% in Mandarin and 1% in Vietnamese). This may not reflect the ethnic breakdown of women attending the antenatal clinics, as most of the women were literate in English regardless of ethnicity. Of the women approached, 337/355 (95%) returned their forms.

The mean (±SD) age of participating woman was 30.7 ± 5.6 years. 109 (32.5%) of women were primigravid. 171 (51.5%) women were born overseas (22.9% from Western

Discussion

The most notable findings of our study were that only 31% of pregnant women and 68% of maternity care providers indicated they were going to receive the influenza vaccine in 2011. Maternity care providers were much more likely to vaccinate their patients if they had been vaccinated themselves in the past two years, and pregnant women were more likely to be vaccinated if they had received education on influenza.

No patient demographic variables were significantly correlated with vaccine uptake,

References (22)

D.J. Jamieson et al.
H1N1 2009 influenza virus infection during pregnancy in the USA
Lancet
(2009)
F.M. Munoz et al.
Safety of influenza vaccination during pregnancy
American Journal of Obstetrics and Gynecology
(2005)
T.K. Mak et al.
Influenza vaccination in pregnancy: current evidence and selected national policies
Lancet Infectious Diseases
(2008)
P.D. Tamma et al.
Safety of influenza vaccination during pregnancy
American Journal of Obstetrics and Gynecology
(2009)
K.A. Poehling et al.
Impact of maternal immunization on influenza hospitalizations in infants
American Journal of Obstetrics and Gynecology
(2011)
P. Lu et al.
Influenza vaccination of recommended adult populations, U.S., 1989–2005
Vaccine
(2008)
G.K. Steelfisher et al.
Novel pandemic A (H1N1) influenza vaccination among pregnant women: motivators and barriers
American Journal of Obstetrics and Gynecology
(2011)
B.M. Fisher et al.
Behaviors and perceptions regarding seasonal and H1N1 influenza vaccination during pregnancy
American Journal of Obstetrics and Gynecology
(2011)
S. Esposito et al.
Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children
Vaccine
(2007)
T. Lee et al.
Beliefs and practices of Ontario midwives about influenza immunization
Vaccine
(2005)

M.H. Yudin et al.

Acceptability and feasibility of seasonal influenza vaccine administration in an antenatal clinic setting

Journal of Obstetrics and Gynaecology Canada

(2010)

Cited by (40)

Knowledge, attitudes, and practices regarding seasonal influenza vaccination during pregnancy in Costa Rica: A mixed-methods study
2022, Vaccine
Influenza increases stillbirth risk, morbidity and mortality in pregnant women. Vaccination protects pregnant women against severe disease and indirectly protects their infants, but coverage among pregnant women remains low worldwide. We aimed to describe knowledge, attitudes, and practices (KAP) regarding seasonal influenza vaccination among postpartum women and prenatal care physicians in Costa Rica.
We conducted cross-sectional KAP surveys to women one to three days after childbirth at Costa Rican Social Security Fund maternity hospitals, and obstetricians and general practitioners who provided prenatal care in 2017. Principal components analysis, multiple imputation, and logistic regression were used to examine associations between influenza vaccination and demographics, prenatal care, and sources of information—separately for postpartum women and physicians. We also held two focus groups of six healthcare workers each to further describe vaccination KAP.
We surveyed 642 postpartum women and 146 physicians in maternity hospitals in five Costa Rican provinces of whom 85.5 % (95 % CI: 82.6 %-88.0 %) and 57.9 % (95 % CI: 49.6 %-65.7 %) were vaccinated for influenza, respectively. Factors associated with influenza vaccination for postpartum women included tetanus vaccination (aOR: 3.62, 95 % CI: 1.89–6.92); received vaccination recommendations from clinicians during prenatal check-ups (aOR: 3.39, 95 % CI: 2.06–5.59); had other children in household vaccinated for influenza (aOR: 2.25, 95 % CI: 1.08–4.68); and secondary/university education (aOR: 0.15–0.31) with no formal education as reference. For postpartum women, reasons for vaccination were perceived benefits for mother and infant, whereas not being offered vaccines was most cited for non-vaccination. Most prenatal care physicians recommended influenza vaccines during prenatal check-ups but believed vaccination causes flu-like symptoms.
Vaccination campaigns and provisions of free vaccines effectively increased knowledge and coverage among women in Costa Rica. To improve access, women should be offered vaccines during prenatal care appointments. Educating healthcare workers about vaccine benefits for themselves and patients is needed to mitigate safety concerns.
The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers’ recommendation of influenza vaccine in pregnancy
2020, Vaccine
WHO recommends influenza vaccination for pregnant women and health providers (HPs), yet global uptake for both is persistently low. Research suggests that HPs greatly influence uptake of influenza vaccine in pregnant women. Our review studies HPs’ recommendation of influenza vaccine to pregnant women, determinants and barriers to recommendation, and the role that HPs may play in global influenza vaccine coverage.
We undertook a comprehensive global review of literature relating to HPs’ recommendation of seasonal influenza vaccines to pregnant women and the determinants and barriers to recommendation and how this may vary by country and context. We evaluated data from each study including frequency of HP recommendation, vaccine coverage, determinants and barriers to recommendation, and the odds of recommending. We tracked the frequency of determinants and barriers to recommendation in heat maps and organized data by world regions and income classifications.
From 32 studies in 15 countries, we identified 68 determinants or barriers to HPs’ recommendation. Recommendation rates were highest (77%) in the Americas and lowest in South East Asia (18%). A HP’s own influenza vaccine status was a main determinant of recommendation in multiple country contexts and from different provider types. Financial barriers to recommendation were present in higher-income countries and policy-related barriers were highlighted in lower-income countries. HP perceptions of safety, efficacy, and the utility of vaccine were the most frequently cited barriers, relevant in almost every context.
HP recommendation is important to influenza vaccine implementation in pregnant women. A HP’s own status is an important recommendation determinant in multiple contexts. Vaccine program implementation plans should consider the impact of HPs' knowledge, awareness and vaccine confidence on their own uptake and recommendation practices, as well as on the uptake among pregnant women. Addressing safety and efficacy concerns is relevant in all contexts for HPs and pregnant women.
Role of health professionals of sexual health and reproduction clinics in the influenza vaccination in pregnant women
2016, Atencion Primaria
What determines uptake of pertussis vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London
2015, Vaccine
Following the major outbreak of pertussis and 14 infant deaths across England in 2012, the Department of Health (DH) introduced the UK's first maternal pertussis vaccination programme. Data published by Public Health England (PHE) suggest uptake of the vaccine varies considerably across the country. The reasons for this heterogeneity need to be addressed to optimise the impact of the programme.
To assess uptake of antenatal pertussis and influenza vaccine in a leading NHS Trust in London and to explore awareness and attitudes of pregnant women towards the pertussis vaccination programme.
A cross sectional survey was conducted in an ethnically diverse group of 200 pregnant women accessing antenatal care at Imperial Healthcare NHS Trust. Quantitative data was tabulated and content analysis was carried out on the free text. Qualitative data was divided into themes for accepting or declining the vaccine.
Awareness of the programme was 63% (126/200) with actual uptake of the vaccine only 26.0% (52/200). Women had received information from multiple sources, primarily General Practitioners (GP) and midwives. 34.0% (68/200) of women were offered the vaccine at their GP practice, only 24% reported a meaningful discussion with their GP about it. Uptake differed by up to 15.0% between ethnicities. Qualitative data showed that uptake could be significantly enhanced if vaccination was recommended by a familiar healthcare professional. Feeling uninformed, lack of professional encouragement and uncertainties of risk and benefit of the vaccine were the greatest barriers to uptake.
Vaccine uptake in this cohort of pregnant women was poor. Understanding the target audience and engaging with key groups who influence women's decision-making is essential. Knowledgeable health care professionals need to recommend the vaccine and provide accurate and timely information to increase success of this important programme.
Improving influenza and Tdap vaccination during pregnancy: A cluster-randomized trial of a multi-component antenatal vaccine promotion package in late influenza season
2015, Vaccine
Citation Excerpt :
Despite these endorsements, national antenatal influenza vaccination coverage estimates hover around 50% and state-based estimates of Tdap vaccine receipt during pregnancy have typically not exceeded 20% [16–18]. Substantial research has explored facilitators and barriers to vaccinating pregnant women, especially against influenza [19–22]. Barriers can arise from a variety of sources, including a woman's personal hesitancy or lack of knowledge about vaccination during pregnancy.
Evidence-based interventions to improve influenza vaccine coverage among pregnant women are needed, particularly among those who remain unvaccinated late into the influenza season. Improving rates of antenatal tetanus, diphtheria and acellular pertussis (Tdap) vaccination is also needed.
To test the effectiveness of a practice-, provider-, and patient-focused influenza and Tdap vaccine promotion package on improving antenatal influenza and Tdap vaccination in the obstetric setting.
A cluster-randomized trial among 11 obstetric practices in Georgia was conducted in 2012–2013. Intervention practices adopted the intervention package that included identification of a vaccine champion, provider-to-patient talking points, educational brochures, posters, lapel buttons, and iPads loaded with a patient-centered tutorial. Participants were recruited from December 2012–April 2013 and included 325 unvaccinated pregnant women in Georgia. Random effects regression models were used to evaluate primary and secondary outcomes.
Data on antenatal influenza and Tdap vaccine receipt were obtained for 300 (92.3%) and 291 (89.5%) women, respectively. Although antenatal influenza and Tdap vaccination rates were higher in the intervention group than the control group, improvements were not significant (For influenza: risk difference (RD) = 3.6%, 95% confidence interval (CI): −4.0%, 11.2%; for Tdap: RD = 1.3%, 95% CI: −10.7%, 13.2%). While the majority of intervention package components were positively associated with antenatal vaccine receipt, a provider's recommendation was the factor most strongly associated with actual receipt, regardless of study group or vaccine.
The intervention package did not significantly improve antenatal influenza or Tdap vaccine coverage. More research is needed to determine what motivates women remaining unvaccinated against influenza late into the influenza season to get vaccinated. Future research should quantify the extent to which clinical interventions can bolster a provider's recommendation for vaccination. This study is registered with clinicaltrials.gov, study ID NCT01761799.
Influenza vaccine during pregnancy, recommendations from healthcare providers, and race/ethnicity in the United States
2024, Archives of Gynecology and Obstetrics

View all citing articles on Scopus

¹: Both authors contributed equally to this study.

View full text

Influenza vaccination uptake amongst pregnant women and maternal care providers is suboptimal

Abstract

Objective

Design, setting and participants

Results

Conclusions

Highlights

Introduction

Section snippets

Methods

Pregnant women

Discussion

Lancet

American Journal of Obstetrics and Gynecology

Lancet Infectious Diseases

American Journal of Obstetrics and Gynecology

American Journal of Obstetrics and Gynecology

Vaccine

American Journal of Obstetrics and Gynecology

American Journal of Obstetrics and Gynecology

Vaccine

Vaccine

Journal of Obstetrics and Gynaecology Canada